Amiodarone pulmonary toxicity

Area of Science:

• Cardiology
• Pulmonology
• Pharmacology

Background:

• Amiodarone pulmonary toxicity (APT) is a serious adverse effect of amiodarone therapy.
• Literature on APT peaked in the mid-1980s, with a subsequent decline, but has increased since the mid-1990s.
• This resurgence suggests APT remains a relevant clinical challenge.

Purpose of the Study:

• To highlight the persistent clinical relevance of amiodarone pulmonary toxicity.
• To underscore the diagnostic challenges associated with APT.
• To emphasize the variable outcomes in managing APT.

Main Methods:

• Literature review and analysis of publication trends related to amiodarone pulmonary toxicity.
• Synthesis of reported clinical cases and outcomes.
• Discussion of diagnostic difficulties and treatment efficacy.

Main Results:

• A significant peak in APT literature occurred in 1983-1984.
• Post-1990s publications indicate a renewed increase in reported APT cases.
• Noninvasive diagnosis of APT remains challenging.
• While many patients achieve good outcomes, some APT cases are refractory to treatment.

Conclusions:

• Amiodarone pulmonary toxicity continues to be an important clinical concern.
• Improved diagnostic strategies and management protocols for APT are needed.
• Ongoing vigilance and research are essential for optimizing patient care regarding amiodarone use.